Kari Iverson
About Kari Iverson
Kari Iverson is the Manager of Post Market Quality at Boston Scientific, with a rich background in technical and clinical roles, particularly in implantable heart devices. She has extensive experience in preclinical and clinical research and serves as a liaison between Boston Scientific and global patient advocacy groups.
Current Position at Boston Scientific
Kari Iverson is currently serving as the Manager-Post Market Quality at Boston Scientific in Saint Paul, Minnesota. She has been in this role since 2018, focusing on quality management and providing support related to post-market surveillance of medical devices.
Previous Roles at Boston Scientific
Kari Iverson has held several roles at Boston Scientific over the years. She served as Principal Product Analyst from 2017 to 2018, Sr. Clinical Trial Manager from 2015 to 2017, and Fellow, Technical Sales Support from 2012 to 2015. Before that, she was the Principal Technical Consultant from 2007 to 2012 and the Manager, Technical Patient Support Services from 2006 to 2007. She started with the company as a Senior Technical Consultant from 2004 to 2006.
Early Career at Guidant CRM
Kari Iverson worked at Guidant CRM before joining Boston Scientific. She held the positions of Clinical Research Associate from 2001 to 2004, Technical Consultant from 1999 to 2001, and Certified Veterinary Technician from 1995 to 1999. All these roles were based in Arden Hills, Minnesota.
Educational Background
Kari Iverson pursued higher education at Bethel University, where she obtained a Master of Arts in Organizational Leadership from 2010 to 2012. She also earned a Bachelor of Arts in the same field from 2005 to 2008. Additionally, she holds an Associate of Arts and Sciences (AAS) in Veterinary/Animal Health Technology from Willmar Technical College, completed between 1993 and 1996.
Technical Expertise in Medical Devices
Kari Iverson has a strong technical background in implantable cardioverter defibrillators and pacemakers. Her extensive experience in preclinical and clinical research makes her an integral part of Boston Scientific's team, where she serves as a direct link between the company and global patient advocacy and support groups for individuals with implanted heart devices.